Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

GeneDx Holdings (WGS) Other Gross PP&E Adjustments (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with $63.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 33.8% to $63.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $63.5 million, a 33.8% increase, with the full-year FY2025 number at $63.5 million, up 33.8% from a year prior.
  • Other Gross PP&E Adjustments was $63.5 million for Q4 2025 at GeneDx Holdings, up from $42.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $131.0 million in Q4 2022 to a low of $33.8 million in Q1 2025.
  • A 5-year average of $77.4 million and a median of $74.0 million in 2022 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: surged 57.58% in 2021, then plummeted 53.04% in 2024.
  • GeneDx Holdings' Other Gross PP&E Adjustments stood at $102.3 million in 2021, then grew by 28.04% to $131.0 million in 2022, then plummeted by 48.25% to $67.8 million in 2023, then plummeted by 30.05% to $47.4 million in 2024, then skyrocketed by 33.8% to $63.5 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Other Gross PP&E Adjustments are $63.5 million (Q4 2025), $42.3 million (Q3 2025), and $36.8 million (Q2 2025).